Prof. Dr. Joachim Kalden


Medizinische Fakultät

Awards / Honours

2002 : Mitgliedschaft Nationale Akademie der Wissenschaften Leopoldina
1999 : Mitgliedschaft Bayerische Akademie der Wissenschaften

Publications (Download BibTeX)

Winthrop, K.L., Weinblatt, M.E., Crow, M.K., Burmester, G.R., Mease, P.J., So, A.K.,... Furst, D.E. (2019). Unmet need in rheumatology: Reports from the Targeted Therapies meeting 2018. Annals of the Rheumatic Diseases, 78(7), 872-878.
Kalden, J., & Schulze-Koops, H. (2017). Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment. Nature Reviews Rheumatology, 13(12), 707-718.
Giniewski, A., Kalden, J., & Jäck, H.-M. (2017). Immunology in Germany: 50th Anniversary of the German Society for Immunology (DGfI). European Journal of Immunology, 47(12), 2012-2016.
Kalden, J. (2016). Biologics. Zeitschrift für Rheumatologie, 75(6), 604-10.
Kalden, J. (2016). Erratum to: Biologics. Zeitschrift für Rheumatologie, 75(10), 998.
Kalden, J. (2015). Pathogenic cells of rheumatic inflammation as the target of modern therapies. Zeitschrift für Rheumatologie, 74(1), 8-13.
Alsalameh, R.J., Casey, R.C., Mollenhauer, J., Kalden, J., Burmester, G.R., & Alsalameh, S.M. (2013). Induction of proliferation and pro-inflammatory cytokine production in rheumatoid arthritis peripheral blood mononuclear cells by a 65 KDa chondrocyte membrane-specific, constitutive target autoantigen (CH65). International Journal of Rheumatic Diseases.
Neubert, K., Meister, S., Moser, K., Weisel, F., Maseda, D., Amann, K.U.,... Voll, R.E. (2008). The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nature Medicine, 14(7), 748-755.

Last updated on 2016-25-11 at 01:01